---
figid: PMC6637598__12885_2019_5916_Fig2_HTML
figtitle: Wnt/Beta-catenin signal transduction pathway
organisms:
- Homo sapiens
- Hepatitis B virus
- Macaca mulatta
- Human papillomavirus type 16
- H1N1 subtype
- Pan troglodytes
- Macaca fascicularis
- Betapolyomavirus macacae
- Hylobates sp.
- Hepatitis delta virus
- Mus musculus
- Rattus norvegicus
- Marmota monax
- Sus scrofa
- Tupaia glis
- Lareunionomyces loeiensis
- clinical samples
- NA
organisms_ner:
- Sus scrofa
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Pan troglodytes
- Macaca fascicularis
- Marmota monax
- Macaca mulatta
- Danio rerio
pmcid: PMC6637598
filename: 12885_2019_5916_Fig2_HTML.jpg
figlink: /pmc/articles/PMC6637598/figure/Fig2/
number: F2
caption: Wnt/β-catenin signal transduction pathway. Wnt binding to the FZD/LRP5/6
  receptor complex leads to inhibition of GSK3 enzyme activity and the β-catenin destruction
  complex, which allows newly synthesized β-catenin to accumulate and translocate
  to the nucleus (orange arrows), where it binds with co-factors to form a transcriptionally
  active complex. Wnt signalling can be inhibited at the cell surface by various naturally
  occurring pathway inhibitors such as sFRPs and DKK, which bind to Wnt and LRP5/6
  respectively. [secreted Frizzled Related Protein (sFRP); Frizzled (FZD); Dickkopf
  (DKK); Glycogen Synthase Kinase 3 (GSK3); Adenomatous Polyposis Coli (APC), Casein
  Kinase 1 (CK1)]
papertitle: 'HBV-related hepatocarcinogenesis: the role of signalling pathways and
  innovative ex vivo research models.'
reftext: Joseph Torresi, et al. BMC Cancer. 2019;19:707.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9449176
figid_alias: PMC6637598__F2
figtype: Figure
redirect_from: /figures/PMC6637598__F2
ndex: ff7fed1b-defc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6637598__12885_2019_5916_Fig2_HTML.html
  '@type': Dataset
  description: Wnt/β-catenin signal transduction pathway. Wnt binding to the FZD/LRP5/6
    receptor complex leads to inhibition of GSK3 enzyme activity and the β-catenin
    destruction complex, which allows newly synthesized β-catenin to accumulate and
    translocate to the nucleus (orange arrows), where it binds with co-factors to
    form a transcriptionally active complex. Wnt signalling can be inhibited at the
    cell surface by various naturally occurring pathway inhibitors such as sFRPs and
    DKK, which bind to Wnt and LRP5/6 respectively. [secreted Frizzled Related Protein
    (sFRP); Frizzled (FZD); Dickkopf (DKK); Glycogen Synthase Kinase 3 (GSK3); Adenomatous
    Polyposis Coli (APC), Casein Kinase 1 (CK1)]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP6
  - LRP5
  - CTNNB1
  - APC
  - CSNK1A1
  - BCL9
  - BP
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - PROC
  - KRT1
  - CSNK1A1L
  - HNF4A
  - AXIN1
  - AXIN2
  - GSK3A
  - GSK3B
  - EP300
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - Lrp6
  - Lrp5
  - Ctnnb1
  - Apc
  - Gm12892
  - Bcl9
  - Axin1
  - Gsk3b
  - Csnk1a1
  - Ep300
  - Crebbp
  - Pag1
  - Cytip
  - Wnt2
  - lrp6
  - lrp5
  - ctnnb1
  - apc
  - bcl9
  - elk4
  - szl
  - tlc
  - gsk3ba
  - gsk3ab
  - csnk1a1
  - Cancer
---
